Unity Biotechnology, Inc. Accounts Payable
Unity Biotechnology, Inc. had Accounts Payable of $1.76 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-04-22
- 2025-03-31: Accounts Payable, Current $1.76M.
- 2024-12-31: Accounts Payable, Current $997.00K.
- 2024-09-30: Accounts Payable, Current $1.80M.
- 2024-06-30: Accounts Payable, Current $1.46M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-03-31 | $1.76M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $997.00K 10-Q · filed 2025-04-22 |
| 2024-09-30 | $1.80M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $1.46M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.40M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.38M 10-K · filed 2025-03-07 |
| 2023-09-30 | $1.15M 10-K · filed 2024-04-15 |
| 2023-06-30 | $1.45M 10-K · filed 2024-04-15 |
| 2023-03-31 | $1.47M 10-K · filed 2024-04-15 |
| 2022-12-31 | $1.79M 10-K · filed 2024-04-15 |
| 2022-09-30 | $2.44M 10-K · filed 2024-04-15 |
| 2022-06-30 | $1.44M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $3.32M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.99M 10-K · filed 2023-03-15 |
| 2021-09-30 | $1.77M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.90M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.98M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.56M 10-K · filed 2022-03-15 |
| 2020-09-30 | $4.25M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $3.95M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $4.01M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.18M 10-K · filed 2021-03-23 |
| 2019-09-30 | $4.58M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $5.38M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $4.07M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $4.85M 10-K · filed 2020-03-11 |
| 2018-09-30 | $2.62M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.88M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $5.04M 10-Q · filed 2018-06-07 |
| 2017-12-31 | $2.38M 10-K · filed 2019-03-06 |